ID

19435

Description

Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist; ODM derived from: https://clinicaltrials.gov/show/NCT00303394

Link

https://clinicaltrials.gov/show/NCT00303394

Keywords

Versions (1)
  1. 1/2/17 1/2/17 -
Uploaded on

January 2, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes NCT00303394

English

Eligibility Type 2 Diabetes NCT00303394

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >20
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diabetes mellitus type 2 (american diabetes association criteria) of at least 3 months duration
Description

Non-Insulin-Dependent Diabetes Mellitus disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
hba1c >7.5%
Description

Glucohemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0202054
body-mass index (bmi) > 27
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
positive gad 65 or ia-2 antibodies at inclusion.
Description

Glutamate decarboxylase 65 antibody Positive | Anti-IA2 antibody positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0806227
UMLS CUI [1,2]
C1514241
UMLS CUI [2]
C3495754
hba1c >12%, polyuria and thirst (exclusion of severely decompensated patients)
Description

Glucohemoglobin measurement | Polyuria | Thirst | Patients Decompensated Severe

Data type

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2]
C0032617
UMLS CUI [3]
C0039971
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C0205434
UMLS CUI [4,3]
C0205082
c-peptide < 400pmol/l (basal )
Description

C-peptide measurement Basal

Data type

boolean

Alias
UMLS CUI [1,1]
C0202100
UMLS CUI [1,2]
C0650607
established anti-inflammatory therapy (includiung cortisone, nsaid, cox-2-inhibitor). low dose aspirin (£ 100mg) will be tolerated.
Description

Antiinflammatory therapy Established | Cortisone | Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Aspirin Low Dose

Data type

boolean

Alias
UMLS CUI [1,1]
C1096024
UMLS CUI [1,2]
C0443211
UMLS CUI [2]
C0010137
UMLS CUI [3]
C0003211
UMLS CUI [4]
C1257954
UMLS CUI [5]
C2608320
crp >30 mg/dl, fever, current treatment with antibiotics, or chronic granulomatous infections (e.g. tuberculosis) in the history or on a screening chest x-ray.
Description

C-reactive protein measurement | Fever | Antibiotic therapy | Granulomatous infection chronic | Tuberculosis | Plain chest X-ray

Data type

boolean

Alias
UMLS CUI [1]
C0201657
UMLS CUI [2]
C0015967
UMLS CUI [3]
C0338237
UMLS CUI [4,1]
C1610637
UMLS CUI [4,2]
C0205191
UMLS CUI [5]
C0041296
UMLS CUI [6]
C0039985
neutropenia or anemia (leucocyte count < 2.0x109 /l, hemoglobin <11g/dl for ma les or <10g/dl for females)
Description

Neutropenia | Anemia | White Blood Cell Count procedure | Hemoglobin measurement | Gender

Data type

boolean

Alias
UMLS CUI [1]
C0027947
UMLS CUI [2]
C0002871
UMLS CUI [3]
C0023508
UMLS CUI [4]
C0518015
UMLS CUI [5]
C0079399
pregnancy or breast-feeding. when appropriate (fertile women),anticonception for at last 3 month prior inclusion will be required.
Description

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
severe liver or renal disease ( ast or alt>3 times the upper limit of normal laboratory range, serum creatinine >130mm)
Description

Liver disease Severe | Kidney Disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0022658
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0151904
UMLS CUI [4]
C0151905
UMLS CUI [5]
C0201976
ongoing malignant neoplasm
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
use of any investigational drug within 30 days of enrollment into the study or within 5 half-lives of the investigational drug (whichever is longer)
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
immunosuppressive treatment or immunodeficient diseases.
Description

Therapeutic immunosuppression | Immunologic Deficiency Syndromes

Data type

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0021051
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes NCT00303394

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age >20
boolean
C0001779 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
diabetes mellitus type 2 (american diabetes association criteria) of at least 3 months duration
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hba1c >7.5%
boolean
C0202054 (UMLS CUI [1])
Body mass index
Item
body-mass index (bmi) > 27
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Glutamate decarboxylase 65 antibody Positive | Anti-IA2 antibody positive
Item
positive gad 65 or ia-2 antibodies at inclusion.
boolean
C0806227 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C3495754 (UMLS CUI [2])
Glucohemoglobin measurement | Polyuria | Thirst | Patients Decompensated Severe
Item
hba1c >12%, polyuria and thirst (exclusion of severely decompensated patients)
boolean
C0202054 (UMLS CUI [1])
C0032617 (UMLS CUI [2])
C0039971 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C0205434 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
C-peptide measurement Basal
Item
c-peptide < 400pmol/l (basal )
boolean
C0202100 (UMLS CUI [1,1])
C0650607 (UMLS CUI [1,2])
Antiinflammatory therapy Established | Cortisone | Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Aspirin Low Dose
Item
established anti-inflammatory therapy (includiung cortisone, nsaid, cox-2-inhibitor). low dose aspirin (£ 100mg) will be tolerated.
boolean
C1096024 (UMLS CUI [1,1])
C0443211 (UMLS CUI [1,2])
C0010137 (UMLS CUI [2])
C0003211 (UMLS CUI [3])
C1257954 (UMLS CUI [4])
C2608320 (UMLS CUI [5])
C-reactive protein measurement | Fever | Antibiotic therapy | Granulomatous infection chronic | Tuberculosis | Plain chest X-ray
Item
crp >30 mg/dl, fever, current treatment with antibiotics, or chronic granulomatous infections (e.g. tuberculosis) in the history or on a screening chest x-ray.
boolean
C0201657 (UMLS CUI [1])
C0015967 (UMLS CUI [2])
C0338237 (UMLS CUI [3])
C1610637 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0041296 (UMLS CUI [5])
C0039985 (UMLS CUI [6])
Neutropenia | Anemia | White Blood Cell Count procedure | Hemoglobin measurement | Gender
Item
neutropenia or anemia (leucocyte count < 2.0x109 /l, hemoglobin <11g/dl for ma les or <10g/dl for females)
boolean
C0027947 (UMLS CUI [1])
C0002871 (UMLS CUI [2])
C0023508 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods
Item
pregnancy or breast-feeding. when appropriate (fertile women),anticonception for at last 3 month prior inclusion will be required.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Liver disease Severe | Kidney Disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased | Creatinine measurement, serum
Item
severe liver or renal disease ( ast or alt>3 times the upper limit of normal laboratory range, serum creatinine >130mm)
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
Malignant Neoplasms
Item
ongoing malignant neoplasm
boolean
C0006826 (UMLS CUI [1])
Investigational New Drugs
Item
use of any investigational drug within 30 days of enrollment into the study or within 5 half-lives of the investigational drug (whichever is longer)
boolean
C0013230 (UMLS CUI [1])
Therapeutic immunosuppression | Immunologic Deficiency Syndromes
Item
immunosuppressive treatment or immunodeficient diseases.
boolean
C0021079 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial